Graduate nursing concentration in women's health at the university of illinois at Chicago

1995 ◽  
Vol 16 (6) ◽  
pp. 491-500 ◽  
Author(s):  
Beverly J. McElmurry ◽  
B. Joan Newcomb
2006 ◽  
Vol 9 (6) ◽  
pp. 865-867 ◽  
Author(s):  
Juan R. Ordoñana ◽  
Francisco Pérez-Riquelme ◽  
Francisca González-Javier ◽  
Eduvigis Carrillo ◽  
Jesús Gómez-Amor ◽  
...  

AbstractThe present article describes the initial steps taken in setting up a twin registry in Spain. The Murcia Twin Registry (MTR) will focus initially on perimenopausal women's health. It will be administered and managed by the University of Murcia and the Murcia Health Council and will start with a database of 452 pairs of female twins born between 1940 and 1965 in the region of Murcia, Spain. Once the MTR is established and has gained some experience, our goal is to expand the age range and include males and opposite-sex twins. The current main areas of research interest are menopause, preventive behaviors, lifestyle and health as well as quality of life.


1997 ◽  
Vol 176 (6) ◽  
pp. 1368-1373 ◽  
Author(s):  
Patricia A. Robertson ◽  
Jeanette S. Brown ◽  
Tracy A. Flanagan ◽  
Mindy E. Goldman ◽  
Lee A. Learman ◽  
...  

2004 ◽  
Author(s):  
Caitlin S. Shannon ◽  
Beverly Winikoff

On May 7–8, 2001, the Population Council and the Center for Reproductive Health Research & Policy of the University of California, San Francisco, convened a technical seminar in New York City on the use of misoprostol for women’s health indications. The seminar was designed to provide a forum for researchers, providers, women’s health advocates, and educators to exchange information with the goal of advancing the potential of misoprostol to improve women’s health. Participants discussed the state of the art in research, examined current clinical use of misoprostol, and created strategies for the future. The first day focused on scientific and clinical aspects of misoprostol use. The second day’s discussion centered on the future of misoprostol for women’s health, including identifying priorities for research and the role of provider groups and women’s health and advocacy organizations in helping to ensure misoprostol’s continued, appropriate use. At the end of each session, the group had an opportunity to share ideas and discuss unanswered questions. This report covers the key issues raised by each speaker and highlights general areas of discussion among participants.


Sign in / Sign up

Export Citation Format

Share Document